Cite
HARVARD Citation
Finnes, H. et al. (2017). Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leukemia & lymphoma. 58 (6), pp. 1376-1383. [Online].